GILD vs SHC · P/E 18, rev $7.80B vs P/E 38, rev $601.4M
Gilead Sciences Inc (GILD) versus Sotera Health Co (SHC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Sotera Health Co (SHC) is a diagnostics & research company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SHC revenue for 2026-06-30 was $601.4M. Net income was $80.2M. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
Not investment advice. Open the GILD and SHC stock pages for the full models.
Not investment advice.